GH001 – also known as mebufotenin – is an inhaled formulation of 5-MeO-DMT, based on a hallucinogenic substance secreted by a species of toad (Bufo alvarius) that has attracted a lot of ...

N-dimethyltryptamine (5-MeO-DMT) heading for phase 2 studies in depression and AUD in combination with psychotherapy. SUNHA candidate dropped There's also been some consolidation of Beckley's own ...

It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). The company’s lead program is GH001 ...

safety and tolerability of VLS-01 (buccal film DMT) in people suffering from treatment-resistant depression - VLS-01 is being developed as a rapid-acting, robust and durable antidepressant for ...